reports
Bank Of Cyprus Holdings: 1 director
A director at Bank Of Cyprus Holdings bought 4,675 shares at 4.270EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Bank of Cyprus Holdings PLC: Date of announcement of 9M2020 Financial ...
Bank of Cyprus Holdings PLC (BOCH) Bank of Cyprus Holdings PLC: Date of announcement of 9M2020 Financial Results 17-Nov-2020 / 10:10 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Announcement Date of announcement of the Bank of Cyprus Group Financial Results for the nine months ended 30 September 2020 Nicosia, 17 November 2020 Bank of Cyprus Holdings Public Limited Company announces that its Board of Directors will convene on Thursday, 26 November 2020...
BANK OF CYPRUS Flash Note, June 2020
Bank of Cyprus Holdings PLC is a Cyprus-based holding company for banking and financial services (the Group). The Company’s primary operating subsidiary is Bank of Cyprus PCL. The Group is organized into operating segments based on the geographic location: Cyprus, the United Kingdom and Other Countries. The Other Countries segment comprises activities in Greece, Romania and Russia. The general activities the Group is engaged in include mainly the provision of banking, financial and insurance ser...
- Alex Boulougouris
solid 4Q numbers, improving asset quality
Bank of Cyprus has reported a solid set of 4Q16 numbers, above our estimates. Net profit (excluding a VRS charge of EUR 16m) came in at EUR 18m in 4Q vs. our forecast of EUR 2m. The beat was even stronger at the pre-provision profit level on the back of solid NII, fees and operating expenses. The cost of risk was in line, but other impairments were elevated due to a EUR 18m charge as provisions for litigations and regulatory matters. On the positive side, we also highlight the further drop in NP...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.